THE LEO & ANNE ALBERT INSTITUTE FOR BLADDER CANCER CARE & RESEARCH (EIN 471075307) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

JOHN TAYLOR III

Phone

8603840275

Tax Period

2023-01-01 to 2023-12-31

THE LEO & ANNE ALBERT INSTITUTE FOR BLADDER CANCER CARE & RESEARCH, founded in 2014, is a micro nonprofit in the Medical Research sector that reported $50K in total revenue in fiscal year 2023. Revenue fell 84% from the prior year — a significant decline worth monitoring. Expenses of $150K exceeded revenue, resulting in a 203% operating deficit.

Mission

MISSION IS TO FOSTER MEDICAL AND SCIENTIC RESEARCH AND EDUCATION IN THE CARE AND TREATMENT OF BLADDER CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $49,535

Investment Income $11

Other Revenue $0

TOTAL REVENUE $49,546

Expense Breakdown

Grants Paid $40,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $144,030

Other Expenses $110,130

TOTAL EXPENSES $150,130

Year-over-Year Comparison

	2023	2022	Change
Revenue	$49,546	$307,589	-0.8%
Expenses	$150,130	$218,403	-0.3%
Net Income	$-100,584	$89,186	-2.1%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

N/A

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN A TAYLOR III	PRESIDENT/DIRECTOR	1.00	Director	$0	$0	$0
JACK CAYNON	SECRETARY	1.00	Director	$0	$0	$0
GENE PRANZO	DIRECTOR	0.00	Director	$0	$0	$0
CAROLYN RUNOWICZ	DIRECTOR	0.00	Director	$0	$0	$0
SCOTT WEIR	TREASURER	0.00	Director	$0	$0	$0
ASHISH KAMAT	DIRECTOR	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$49,546	$150,130	$167,113	$-100,584
2022	$307,589	$218,403	$267,697	$89,186
2021	$101,515	$69,127	$178,511	$32,388
2020	$152,246	$93,174	$146,123	$59,072
2019	$259,169	$233,611	$87,051	$25,558
2018	$257,502	$258,388	$61,493	$-886

THE LEO & ANNE ALBERT INSTITUTE FOR BLADDER CANCER CARE & RESEARCH